Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

2012147 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Infectious Diseases

Volume 12, Issue 9, pp. 671-677

Field-Weighted Citation Impact: 15.76